Skip to main content
COVID-19 research at Rockefeller


photo of SARS-CoV-2's helicase-polymerase coupling

A never-seen-before image of the coronavirus copy machine

August 7, 2020
The high-resolution 3D image can speed COVID-19 drug discovery.
Read more


photo of cells

How toothless mock viruses could advance research on COVID-19

July 31, 2020
Scientists have engineered four viruses resembling SARS-CoV-2 to enable faster and safer research on vaccines and treatments.
Read more


photo of hepatitis c helicase

Amid the rush for COVID-19 drugs, a case for the helicase

July 28, 2020
The enzyme is essential for the virus to replicate itself inside our cells. Scientists already have ideas for how to block it.
Read more


photo of llama

How antibodies from llamas may lead to COVID-19 treatment

June 11, 2020
Llamas make antibodies that are much smaller than their human counterparts, yet still potent. Scientists hope that future drugs based on these molecules could provide new weapons against SARS-CoV-2.
Read more


illustration of antibodies

First results from human COVID-19 immunology study reveal universally effective antibodies

May 25, 2020
New findings characterize human antibody response to SARS-Cov-2, with implications for convalescent plasma therapy, vaccine design, and antibody-based drugs.
Read more


Kawasaki disease

Rockefeller scientists investigate life-threatening inflammation affecting children with COVID-19

May 15, 2020
The condition resembles a rare childhood illness, Kawasaki disease. Researchers are analyzing blood samples to find genetic clues to what might be causing it.
Read more


DNA on a screen

The gene hunt to explain why some young, healthy people die from COVID-19

April 30, 2020
People under 50 without preexisting conditions typically develop mild symptoms of coronavirus infection—but there are exceptions. Researchers are working to identify rare genetic variations that may explain why some in this group have succumbed to the disease.
Read more


A volunteer who has recovered from COVID-19 donates blood.

Scientists are using 'elite' antibodies from COVID-19 survivors to develop potent therapies

April 21, 2020
Most people infected with the coronavirus are able to fight it off because their immune system produces effective antibodies. Rockefeller scientists are working to turn such antibodies into a drug.
Read more



Stavros Niarchos Foundation donates $3 million to Rockefeller COVID-19 research

April 14, 2020
The grant bolsters Rockefeller’s round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
Read more




Citadel accelerates Covid-19 testing and treatment initiatives to enhance community resilience across the nation

April 6, 2020
The partners of Citadel and Citadel Securities announced $5 million of support to advance scientific relief initiatives at four New York City medical institutions, including Rockefeller.
Read more



BSL 3 Laboratory

Rockefeller scientists launch a broad range of studies into novel coronavirus

April 3, 2020
Over 130 scientists in 18 labs are conducting research to advance the development of new, urgently needed approaches for the prevention and treatment of COVID-19.
Read more


A never-seen-before image of the coronavirus copy machineAugust 7, 2020The high-resolution 3D image can speed COVID-19 drug discovery.Read more How toothless mock viruses coul